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Abstract
Background: Habitual (non-exercise) physical activity (PA) declines with age, and aging-related increases in inflammation and fatigue may be 
important contributors to variability in PA.
Methods: This study examined the association of objectively-measured PA (accelerometry over 7 days) with inflammation (plasma interleukin-6 
and C-reactive protein) and with self-reported fatigue (SF-36 Vitality) at baseline and 18 months after a diet-induced weight loss, exercise, or 
diet-induced weight loss plus exercise intervention in 167 overweight/obese, middle-aged, and older adults.
Results: At baseline, individuals with higher plasma interleukin-6, as well as those who reported feeling less energetic (more fatigued), took 
less steps per day and had lower PA energy expenditure and minutes of light and moderate–vigorous PA (p < .05 for all). At the 18-month 
follow-up, inflammation was lower in both weight loss groups, fatigue was reduced in all three groups with larger decreases in the combined 
group, and mean levels of habitual PA were not changed in any group. In longitudinal analyses with all groups combined, we found that 
participants reporting larger increases in vitality (eg, declines in fatigue) had greater increases in PA (p < .05 for all). Also, changes in steps/d 
and physical activity energy expenditure were indirectly associated with changes in interleukin-6 (β [SEM] for steps/d = −565 [253]; β [SEM] 
for physical activity energy expenditure = −22.4 [10.17]; p < .05).
Conclusions: Levels of habitual PA are lower in middle-aged and older adults with higher levels of chronic inflammation and greater self-
reported fatigue. In addition, participants who experienced greater declines in inflammation during the interventions had greater declines in 
fatigue and larger increases in PA.
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Physical activity (PA) is comprised of both “purposeful” exercise, 
as well as non-exercise movement comprised primarily of mobility-
related activities occurring throughout the day. This habitual (non-
exercise) activity declines across the lifespan (1), an observation that 
is biologically inherent to aging, as it is evident even among highly fit 
older exercisers (2) and is observed across species (3). Habitual PA is 
inversely related to sedentary behavior (sitting or lying down), and 
more sedentary behavior is associated with worse physical function 
and loss of mobility in older adults, even independent of structured 
exercise (4–6).
Despite the fundamental ubiquitous nature of reduced habitual 
PA with age, very little is known regarding the biological, envi-
ronmental, and/or psychosocial factors that contribute to one’s 
propensity to move and to inter-individual variation in move-
ment. An important factor underlying less habitual activity may be 
fatigue, or the subjective lack of physical and/or mental energy (7). 
Fatigue also increase with age (8,9), and some studies report an asso-
ciation between fatigue and low levels of PA and greater sedentary 
behavior (10–17). However, the biological link between fatigue and 
sedentary behavior is not known. Acute inflammation from infection 
results in fatigue (ie, “sickness behavior”) and chronic inflammation 
underlies fatigue symptoms common to specific diseases (18–21). 
Aging is characterized by an increasingly elevated pro-inflammatory 
state, but one that is far below that observed during acute infections 
or disease states (22–24). This persistent, low-grade inflammation is 
likely a contributing factor to loss of muscle function and onset of 
disability with age (25,26); however, its role in fatigue and reduced 
PA is less studied (14,15,27,28).
The purpose of this study was to determine the cross-sectional 
and longitudinal relationships of objectively-measured habitual PA 
to biomarkers of inflammation and self-reported fatigue in mid-
dle-aged and older adults. We examined these relationships using 
baseline and follow-up data collected from participants before and 
18  months after either: diet-induced weight loss alone, exercise 
alone, or diet-induced weight loss plus exercise. We hypothesized 
that individuals with higher inflammation would report feeling more 
fatigued and have lower levels of PA at baseline; and that individual 
changes in habitual PA over the 18 months of intervention would 
be associated with individual changes in inflammation and fatigue, 
independent of treatment arm.
Methods
Study Design and Participants
This analysis used data from a random sub-sample (n  =  167) of 
454 total participants enrolled in the Intensive Diet and Exercise 
for Arthritis study (IDEA; conducted between July 2006 and April 
2011), an 18-month, randomized, controlled trial of the effects of 
three interventions: Diet-induced weight loss only (Diet, N  =  49); 
Exercise only (Exercise, N = 60); and Exercise in combination with 
diet-induced weight loss (Diet+Exercise, N = 58). The participants 
in the sub-sample were those randomly assigned at baseline to addi-
tional/ancillary assessments outside the primary outcomes, includ-
ing accelerometer measurement of PA. Complete details of the trial 
design, methodology, and main results are published (29).
Briefly, ambulatory, middle-aged and older (≥55  years), over-
weight or obese (body mass index [BMI] = 27–41 kg/m2) men and 
women were enrolled if they met  all inclusion/exclusion criteria, 
including: (a) Kellgren Lawrence grade II-III (mild to moderate) 
radiographic tibiofemoral osteoarthritis of one or both knees; (b) 
not performing more than 30 min/wk of exercise in past 6 months; 
(c) no cognitive impairment or depression; (d) no knee surgery in 
prior 6  months; and (e) no clinically relevant comorbid disease 
that would pose a safety threat or impair ability to participate. The 
Wake Forest University Health Sciences Institutional Review Board 
approved the study and all participants gave written informed con-
sent to participate.
Interventions
Details of the interventions are published (29). The diet-induced 
weight loss intervention consisted of group and individual nutri-
tion education and behavioral sessions, as well as an individualized 
dietary prescription plan providing an energy-intake deficit of 800–
1,000 kcals/d to reach an average weight loss goal of 10% of base-
line weight. The prescribed diet provided an energy intake deficit of 
800 to 1,000 kcal/d as predicted by estimated weight-maintenance 
energy expenditure (estimated resting metabolic rate × 1.2 activity 
factor) with at least 1,100 kcal/d for women and 1,200 kcal/d for 
men. There was one individual session and three group sessions 
per month for the first 6 months. From months 7–18, participants 
attended biweekly group sessions, with an individual appointment 
every 2  months. The Exercise-only group was not counseled to 
restrict caloric intake during the study.
The exercise intervention took place 3 days per week. Each ses-
sion consisted of a 5-minute dynamic warm-up, an aerobic phase 
(over ground walking) for 15 minutes, followed by light strength 
training (20 minutes) and a second aerobic phase of over ground 
walking for 15 minutes, and then a cool-down with stretching (10 
minutes). During the first 6  months, each session was supervised 
and center-based. Starting at month 7, participants could continue 
to exercise in the research center for all 3 d/wk (chosen by 67% of 
participants), or could opt for a home-based program (11%), or a 
combination of center- and home-based (22%). Exercise prescrip-
tions were individualized based on a participant’s ability. Briefly, 
the walking intensity prescription progressed from 50% to 60% of 
heart rate reserve initially to 75%–85% of HRR; the strength train-
ing workload was also progressive with participants increasing the 
weight lifted every fifth to sixth session during the first 6 months, 
and then maintained that weight for 12 months.
Measurements
Demographic characteristics were obtained through self-report ques-
tionnaires, and included age, sex, race, and years of education. Body 
height and weight were assessed in the clinic without shoes or heavy 
clothing on a calibrated scale using standard techniques. Self-reported 
pain and function were assessed using the Western Ontario McMasters 
Universities Osteoarthritis Index (WOMAC). Perception of fatigue was 
assessed using the Vitality domain on the original Medical Outcomes 
Study 36-item short-form (SF-36) measure (30). The Vitality sub-scale 
consists of four items assessing vitality/fatigue levels in the past month 
on a 6-point scale from 1 (“all of the time”) to 6 (“none of the time”). 
The questions are: (a) Did you feel tired?; (b) Did you feel worn out?; 
(c) Did you feel full of pep?; and (d) Did you have a lot of energy? 
Scores are linearly transformed to a scale of 0 to 100, with higher 
scores indicating higher vitality (ie, less fatigue). A summary vitality/
fatigue score was calculated by averaging the four scores.
Physical activity
The Kenz Lifecorder EX accelerometer (Suzuken Co., Ltd) was used 
to objectively quantify daily PA levels. The device was attached to 
a belt or waistband of the participant’s clothing during all waking 
hours (excluding time for swimming or bathing) for seven consecu-
tive days and the display was locked to avoid providing feedback. 
The device provides valid and reliable measures of steps/d, physical 
activity energy expenditure (PAEE, in kcal/d), and minutes of light, 
moderate, and vigorous PA in free-living conditions (31). A maxi-
mum pulse over 4 seconds was taken as the acceleration value and 
activities were categorized based on intensity levels (1 or minimal 
intensity to 9 or maximal intensity). When the sensor detected three 
acceleration pulses or more for four consecutive seconds, the activ-
ity was recognized as PA. If an acceleration pulse was not immedi-
ately followed by another acceleration pulse then it was not counted 
as a 0 but as a 0.5. This assumed isolated spurts of acceleration 
were changes in posture and not PA. PA was categorized as light 
(<3 Metabolic Equivalents), moderate (3–6 Metabolic Equivalents), 
or vigorous (>6 Metabolic Equivalents) intensity (32). Participants 
maintained accelerometer diaries to note the time of day the device 
was worn. The accelerometer data were uploaded to a computer for 
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analysis and outcome variables included: total steps/d, PAEE, min-
utes of light physical activity (Light PA), and minutes of moderate or 
vigorous physical activity (Mod–Vig PA).
Inflammatory biomarkers
Blood samples were collected in the early morning after a 12-hour 
fast. All follow-up samples were collected at least 24 hours after 
an exercise session and blood sampling was postponed (1–2 weeks 
after recovery of all symptoms) in the event of an acute respiratory, 
urinary tract, or other infection. Plasma interleukin-6 (IL-6) assays 
were run using Quantikine enzyme-linked immunosorbent kits 
from R&D systems (Minneapolis, MN) and high-sensitivity CRP 
was assessed using an automated immunoanalyzer (IMMULITE; 
Diagnostics Products Corporation, Los Angeles, CA) (31).
Statistical Analysis
Baseline characteristics are presented overall using descriptive meas-
ures. Inflammatory biomarkers were assessed on the log-scale due to 
right skewness. Pearson partial correlations were estimated between 
baseline PA measures and both fatigue and inflammation at baseline, 
adjusted for age, gender, race, and BMI. Treatment effects on PA, 
inflammation, and fatigue at 6 and 18 months was assessed using 
mixed linear models adjusted for visit, visit-by-treatment interac-
tion, gender, baseline BMI, and baseline values of the outcome; 
visit-specific means and p-values were estimated using contrast 
statements, assuming an AR (1) covariance. Associations between 
6- and 18-month changes in PA and 6- and 18-month changes in 
fatigue and inflammation were analyzed using Pearson partial cor-
relations, adjusted for baseline age, sex, race, and baseline BMI. We 
also analyzed these associations averaging across time points using 
mixed linear models to account for repeated measures. One model of 
the association between change in PA and change in vitality/fatigue, 
and another model between change in PA and change in inflamma-
tory biomarker, were adjusted for randomization group, visit, group-
by-visit interaction, sex, baseline BMI, and baseline value of the PA 
outcome.
All tests were performed assuming a 2-sided alternative hypoth-
esis at a .05 level of significance. Due to the exploratory nature of the 
substudy, no adjustment for multiplicity was performed. All analyses 
were conducted using SAS v9.4.
Results
Participant Baseline Characteristics
Demographic and other characteristics of the study sample at base-
line are shown in Table 1. Briefly, participants were predominantly 
women, college-educated, and white. All were either overweight or 
obese and the average number of comorbidities was 1.8 ± 1.1. The 
CRP and IL-6 levels in this overweight/obese sample of middle-aged/
older adults are considered to be elevated compared to the general 
population (33); however, there was large variability in these inflam-
matory markers. The SF-36 Vitality (fatigue) scores, as well as the 
PA data, also indicate large inter-individual variability among the 
study sample.
Cross-sectional Associations Among Inflammation, 
Fatigue, and PA at Baseline
To determine whether individuals with higher chronic inflammation 
and greater fatigue have lower levels of habitual PA, we calculated 
Pearson correlation coefficients (adjusting for age, sex, race, and 
BMI) among all variables at baseline. There was a significant inverse 
relationship between IL-6 concentrations and PA, such that those 
with higher plasma IL-6 were less active across each measure of PA 
(steps/d: r = −.20; PAEE: r = −.21; light PA: r = −.16; Mod–Vig PA: 
r = −.19; all p < .05). CRP concentrations only correlated with PAEE 
(r  =  −.16, p < .05). In addition, there were small, but significant, 
positive correlations between PA and the SF-36 Vitality score, such 
that those who reported feeling more energetic (less fatigued) were 
more active (steps/d: r = .19, p < .05; PAEE: r = .16, p < .05; light PA: 
r = .18, p < .05; Mod–Vig PA: r = .14, p = .07). Self-reported vital-
ity/fatigue levels did not correlate with CRP or IL-6 concentrations.
Treatment Effects on Inflammation, Fatigue, and PA
By design, there was a significant loss of body mass in both Diet 
and Diet+Exercise compared to Exercise, but no difference in weight 
lost between weight loss groups (Diet  =  −10.7 ± 7.3 kg, 14.1%; 
Diet+Exercise  =  −11.0 ± 9.5 kg, 14.3%; Exercise  =  0.1 ± 3.6 kg, 
0.2%; p < .0001). Table 2 shows the 6-month and 18-month treat-
ment effects on the inflammation, vitality/fatigue, and PA variables, 
adjusted for baseline BMI, sex, and baseline value of each meas-
ure. Treatment effects on inflammation showed that both Diet and 
Diet+Exercise had lower CRP and IL-6 than Exercise at both 6- and 
Table 1. Baseline Demographic and Health Characteristics of the 
Study Sample
Mean ± SD or # (%)
Age (y) 66.2 ± 6.4
Female, n (%) 116 (70%)
White, n (%) 135 (81%)
Weight (kg) 92.9 ± 14.5
Education
 Less than High School 49 (29%)
 College or Grad school 118 (71%)
Body mass index (kg/m2) 33.5 ± 3.7
Percentage body fat (%) 39.6 ± 7.0
Self-reported comorbidities, n (%)
 Hypertension 105 (64%)
 Cardiovascular disease 13 (8%)
 Diabetes 24 (15%)
 Osteoporosis 18 (11%)
 Any Cancer 35 (22%)
WOMAC pain score 5.9 ± 2.8
WOMAC function score 22.3 ± 10.3
Inflammation
 CRP (mg/L) 8.2 ± 10.1
 IL-6 (pg/mL) 3.1 ± 2.0
SF-36 Vitality questions
 Feeling tired 59.3 ± 23.0
 Feeling worn-out 69.0 ± 22.7
 Feeling energetic 44.3 ± 25.0
 Feeling peppy 46.5 ± 24.0
 SF-36 Vitality summary score 54.8 ± 19.5
Accelerometer-measured physical activity (PA)
 Steps/d 6,143 ± 2,558
 PA energy expenditure (kcal/d) 234 ± 125
 Light PA (min/d) 130 ± 39
 Mod–Vig PA (min/d) 10.5 ± 9.3
Note: N  =  167; SF-36 scale (each question scaled as 0  =  fatigued to 
100 = energetic; higher scores indicate feeling more energetic/less fatigued);
CRP  =  C-reactive protein; IL-6  =  interleukin-6; Mod–Vig PA  =  moderate 
or vigorous physical activity; WOMAC  =  Western Ontario and McMaster 
Universities Osteoarthritis Index.
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18-months; this is consistent with what was reported in the entire 
cohort previously (29,31). The treatment effects on self-reported 
vitality/fatigue are shown in Table  2 and Figure  1. Overall, there 
were significant increases across all three groups in their SF-36 
Vitality score (eg, decrease in fatigue). By the 18-month time point, 
the combined group of Diet+Exercise reported feeling more energetic 
(less fatigued) than either Exercise or Diet (p < .05). The number of 
minutes of Mod–Vig PA was greater in the Exercise groups (Exercise 
and Diet+Exercise); however, there were no group differences in any 
of the other PA measures at 6 or 18 months.
Longitudinal Associations Among Inflammation, 
Fatigue, and PA
Pearson correlation coefficients (adjusted for baseline age, sex, race, 
and BMI) among changes in inflammation, fatigue and PA are shown 
in Table 3. Changes in all of the PA variables correlated positively 
with changes in the SF-36 Vitality score, especially at the 6-month 
time point, whereby individuals with a larger increase in vitality (ie, 
greater reduction in fatigue) exhibited greater increases in PA. There 
were negative correlations between changes in both CRP and IL-6 
and changes in the SF-36 Vitality score, such that greater increases 
in vitality (ie, greater reductions in fatigue) correlated with larger 
declines in inflammation. Changes in PA were not related to changes 
in CRP at either time point; however, changes in steps per day and 
light PA correlated negatively with changes in IL-6 at 18-months.
We also determined whether longitudinal changes in PA were 
associated with changes in vitality/fatigue or inflammation using 
mixed model linear regression. Modeling the associations between 
changes in vitality/fatigue and the PA variables showed there were 
positive associations among changes in each PA variable and changes 
in the SF-36 Vitality score (β [SEM] for steps/d  =  38.31 [9.74]; 
PAEE  =  1.61 [0.40]; light PA  =  0.44 [0.19]; Mod–Vig PA  =  0.13 
[0.03]; p < .05 for all). Modeling associations between change in 
inflammation and the PA variables showed changes in PA were not 
associated with changes in CRP, but changes in steps/d and PAEE 
were indirectly associated with changes in IL-6 levels (steps/d = −565 
[253]; PAEE = −22.4 [10.17]; p < .05).
Discussion
This paper took advantage of existing data from a lifestyle inter-
vention trial to examine the cross-sectional and longitudinal 
Table 2. Inflammation, SF-36 Vitality Score, and Physical Activity by Treatment Group
Diet Only Exercise Only Diet+Exercise Overall
Mean (95% CI) Mean (95% CI) Mean (95% CI) p-value
Log CRP (mg/L) Baseline 1.48 (1.14; 1.83) 1.72 (1.46; 1.97) 1.39 (1.08; 1.69)
6-month 1.10 (0.94; 1.26) 1.51 (1.36; 1.67) 1.15 (1.00; 1.30) <.001
18-month 0.90 (0.74; 1.06) 1.37 (1.21; 1.53) 0.88 (0.73; 1.04) <.0001
Log IL-6 (pg/mL) Baseline 0.82 (0.62; 1.01) 0.92 (0.77; 1.06) 1.09 (0.93; 1.26)
6-month 0.75 (0.65; 0.85) 0.91 (0.82; 1.01) 0.79 (0.70; 0.88) .04
18-month 0.72 (0.62; 0.82) 0.96 (0.86; 1.06) 0.72 (0.63; 0.82) <.001
SF-36 Vitality score Baseline 57.0 (51.4; 62.7) 53.6 (48.5; 58.7) 54.1 (49.0; 59.1)
6-month 62.1 (59.3; 64.9) 62.2 (59.5; 65.0) 65.4 (62.7; 68.0) .14
18-month 61.3 (58.6; 64.0) 61.7 (59.0; 64.4) 66.4 (63.7; 69.1) .01
Steps/d Baseline 5,886 (5,198; 6,573) 6,548 (5,914; 7,182) 5,942 (5,211; 6,673)
6-month 6,258 (5,462; 7,053) 5,521 (4,755; 6,287) 6,207 (5,475; 6,939) .29
18-month 5,252 (4,176; 6,329) 4,686 (3,745; 5,627) 5,963 (4,775; 7,151) .23
PAEE (kcal/d) Baseline 219 (187; 251) 252 (220; 285) 228 (193; 264)
6-month 223 (189; 258) 213 (179; 246) 223 (191; 255) .86
18-month 182 (136; 228) 164 (123; 204) 206 (156; 257) .40
Light PA (min/d) Baseline 135 (123; 147) 132 (123; 142) 124 (115; 134)
6-month 133 (118; 148) 119 (104; 134) 126 (112; 140) .39
18-month 109 (87; 131) 107 (88; 126) 131 (107; 155) .23
Mod–Vig PA (min/d) Baseline 7.9 (5.8; 10.0) 12.1 (9.7; 14.6) 11.1 (8.4; 13.8)
6-month 9.8 (7.2; 12.4) 8.8 (6.2; 11.3) 12.4 (10.0; 14.7) .09
18-month 7.9 (4.1; 11.7) 6.3 (3.1; 9.6) 15.7 (11.6; 19.9) <.01
Note: No differences between groups at baseline: Diet (Baseline N = 49, 18-month N = 41); Exercise (Baseline N = 60, 18-month N = 41); Diet+Exercise (Base-
line N = 58, 18-month N = 43). SF-36 Vitality scale (higher scores indicate feeling more energetic/less fatigued); CI = confidence interval; CRP = C-reactive protein; 
IL-6 = interleukin-6; Mod–Vig PA = moderate or vigorous physical activity; PAEE = physical activity energy expenditure.
Figure 1. Treatment effects on perceived energy/fatigue from SF-36 Vitality 
questions. 6- and 18-month means are adjusted for baseline body mass 
index (BMI), sex, and baseline Vitality score. Significant (p < .05) increases 
within all three groups; Significant (p  =  .01) 18-month difference between 
Diet+Exercise and Exercise-Only or Diet-Only.
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relationships of objectively-measured habitual PA with biomark-
ers of chronic inflammation and levels of perceived fatigue, two 
factors likely to contribute to one’s propensity to move through-
out the day. In cross-sectional analyses with baseline data, we 
found relatively weak, but statistically significant, correlations 
between inflammation and PA, and between fatigue and activity. 
Participants with higher inflammation (especially IL-6) had fewer 
steps per day and fewer minutes of light, moderate and vigorous 
activity, independent of age, sex, race, and baseline BMI. These 
results are consistent with several prior observational studies 
reporting an inverse relationship between inflammation and PA 
(34–36). However, the premise of most of these studies was that 
PA is the predictor variable, and conclusions drawn suggest engag-
ing in more activity, especially that of a higher-intensity, lowers 
inflammation (37,38). Our premise is that the converse is also 
true, that inflammation contributes to lowering of activity, pos-
sibly through increasing fatigue, as we (in this study), and others 
(10–17), find that those who report more fatigue are less active. 
Though in our data from overweight/obese older adults with prev-
alent knee osteoarthritis, there was no cross-sectional association 
between inflammation and fatigue using the Vitality domain of 
the SF-36, a few other studies do show a link between inflam-
mation and fatigue in healthy (15,27,28) and diseased (18–21) 
populations.
The link between habitual PA and inflammation may be a 
“vicious cycle” whereby elevated chronic inflammation leads 
to fatigue and less activity throughout the day (eg, more time 
spent lying or sitting or in sedentary behavior), and in turn, 
inactivity leads to higher inflammation, making it difficult to 
decipher exact causal links between them. This idea is supported 
by recent work showing individuals who spend more time sit-
ting have an elevated inflammatory profile, independent of time 
spent in moderate or vigorous PA (39–41). Disrupting this cycle 
with experimental studies that decrease inflammation are needed 
to definitively confirm the idea that not only acute, but also 
chronic, inflammation is a risk factor for sedentary behavior and 
reduced habitual activity.
Although not the primary purpose of our study, we also reported 
mean effects of the interventions on inflammation, fatigue, and 
habitual PA. These analyses confirmed the already known effects of 
weight loss for lowering inflammation (35,42) as both CRP and IL-6 
levels were much lower in the diet groups after treatment, compared 
to exercise only. However, despite greater weight loss and less inflam-
mation in both diet groups, the combined diet and exercise group 
reported less fatigue at 18-months compared to either exercise or 
diet alone. The positive effects of the diet and exercise combination 
on the SF-36 Vitality domain is in line with the overall conclusion 
of a recent systematic review (of studies in younger and middle-aged 
individuals) which found vitality was the most responsive sub-scale 
of the SF-36 to small decreases in body weight in response to life-
style interventions (43). Notably, there were no group differences 
in habitual PA, although the combined treatment group engaged in 
approximately 8–9 more minutes of Mod–Vig activity per day at the 
18-month follow-up compared to the other treatment arms.
We took advantage of the 18-month interventions to examine 
temporal relationships between PA and inflammation and fatigue. In 
correlation analyses, using data collapsed across treatment groups, 
participants with larger individual declines in both CRP and IL-6 had 
greater improvements in their SF-36 Vitality score (indicative of less 
fatigue), independent of treatment group and demographic charac-
teristics. Importantly, those with larger declines in IL-6 and greater 
decreases in fatigue were those that exhibited a greater increase in 
number of steps/d and PAEE. Thus, it appears that the cycle between 
inflammation and propensity to move throughout the day may have 
been “disrupted” in those who experienced a larger decrease in inflam-
mation. Of course, since, to our knowledge, these are the first data to 
show a longitudinal association of individual changes in habitual PA 
with changes in inflammation, additional research is needed to con-
firm that treating or lowering inflammation per se will result in less 
fatigue and greater habitual movement among older adults.
The results of this study need to be interpreted in light of the 
limitations to our study design, subject sample, and assessments. 
First, this was a retrospective analysis of existing data from a study 
that was designed for a separate purpose. Therefore, the findings 
are limited to middle-aged and older adults who were overweight or 
obese and had knee osteoarthritis, but were otherwise fairly healthy 
and functional. Also, there was no non-intervention control group 
that did not undergo either a diet or exercise intervention. Thus, we 
are not able to definitively determine the effects of either the dietary 
weight loss or exercise intervention on study outcomes; but can 
only determine the effects of the combination of diet plus exercise 
compared to either treatment alone. The measures of inflammation 
were limited to two biomarkers. The fatigue measure available in 
this study, the SF-36 Vitality sub-score, is a commonly used meas-
ure, but is not specific for older adults. Also, it does not incorporate 
the construct of fatigability, or fatigue in the context of a standard-
ized task, that accounts for the concept of self-pacing in order to 
lower exertion or activity to reduce perceived fatigue. Finally, there 
are other factors that we were unable to measure, including diet, 
comorbid disease, medication use, etc., which can affect PA, inflam-
mation and fatigue and may have confounded the associations we 
observed.
Table 3. Pearson Correlations Among 6- and 18-Month Changes in the SF-36 Vitality Score, Inflammation, and Physical Activity
N Steps/d PAEE Light PA Mod–Vig PA Log CRP Log IL-6
SF-36 Vitality score 6-monthΔ 87 0.41 (p < .01) 0.40 (p < .01) 0.24 (p < .05) 0.39 (p < .01) −0.28 (p = .01) −0.29 (p = .01)
18-monthΔ 39 0.34 (p < .05) 0.30 (p = .08) 0.24 (p = .17) 0.37 (p < .05) −0.14 (p = .43) −0.26 (p = .13)
Log CRP 6-monthΔ 88 −0.06 −0.01 −0.04 −0.05 — —
18-monthΔ 39 −0.04 0.03 −0.03 −0.14 — —
Log IL-6 6-monthΔ 88 −0.16 −0.16 −0.05 −0.12 — —
18-monthΔ 39 −0.32 (p = .07) −0.27 (p = .12) −0.36 (p < .05) −0.15 — —
Note: Change scores calculated as Post-value at 6- or 18-months minus Pre-value. SF-36 Vitality score (greater negative change indicates more fatigued). 
Δ  =  6-month or 18-month changes from baseline; CRP  =  C-reactive protein; IL-6  =  interleukin-6; Mod–Vig PA  =  moderate or vigorous physical activity; 
PAEE = physical activity energy expenditure.
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Taken together, the results of this study advance our under-
standing of the biological and psychosocial correlates of individ-
ual variation in habitual PA among middle-aged and older adults 
with obesity. Additional work is needed to determine whether 
increases in chronic inflammation with aging and chronic dis-
ease directly contribute to aging-related increases in fatigue, 
which in turn lead to less propensity to move and greater time 
spent in sedentary behavior with aging. Additional research is 
also needed to determine whether intervening to lower inflam-
mation will result in less fatigue and sedentary behavior which 
would have major relevance for maintaining health and function 
in older adults.
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